Stock Caveat Emptor Status Changes 04/23/2018 04/19/2018

Arch Biopartners Announces Private Placement to Enhance Growth Arch Biopartners Inc. is excited to share that it has successfully arranged a non-brokered private placement. This offering consists of 225,806 common shares priced at $1.55 each, aiming to raise gross proceeds of $350,000 CAD. This strategic move positions Arch to bolster its working capital, which is...

Trilobio Unveils Comprehensive Lab Automation Platform At the forefront of advancing biology research, Trilobio has introduced a groundbreaking whole lab automation platform at a major conference. This innovative platform integrates robotics, lab equipment, and software, creating a streamlined solution for researchers facing workflow challenges. Transforming Genetic...

Shell's Strategic Share Buyback Initiative Shell plc recently announced a significant purchase of shares for cancellation, reaffirming its dedication to enhancing shareholder value. On a specific date, the company acquired a substantial number of shares, a move that is part of the broader share buyback program that was outlined in detail previously. Details of Share...

Constellium SE to Share Q3 2024 Financial Update Constellium SE (NYSE: CSTM) is preparing to reveal its third-quarter 2024 results during a special conference call and webcast. This event will occur on a Wednesday morning, aiming to keep stakeholders informed and engaged with the company's latest developments. Details of the Upcoming Conference Call The conference call is...

Expanding Horizons: Streamline Health’s New Contract Streamline Health Solutions, Inc. (NASDAQ: STRM) has recently announced a notable contract for its RevID technology with a health system based in Kentucky. This particular system is a 120-bed facility that utilizes Oracle Health's EHR, marking a significant step in Streamline Health's expansion within the healthcare...